Vitro Diagnostics Inc. (fka VODG)

[Potse]

Quincy Tam...Noriyuki Kasahara's research lab......

In the "Customer Data" section of the Neuromics website is an image of VODG's stem cells cultured in MSC-Gro media. The image is provided by Quincy Tam (a Staff Research Associate in Noriyuki Kasahara's research laboratory)......

Quincy Tam
Staff Research Associate

Quincy received her bachelor's degree in Molecular, Cell & Developmental Biology from the University of California, Santa Cruz. She worked in medical diagnostics as she continued to pursue her education and became certified in stem cell technology. Quincy joined the Kasahara lab in 2011, and her study focuses on the delivery of RRV (replication retroviral vector) to glioblastoma using stem cell based carriers.

Noriyuki Kasahara, MD, PhD
Director, JCCC Vector Shared Resource & CURE Vector Core Facility
Professor, Departments of Medicine and Molecular & Medical Pharmacology
David Geffen School of Medicine at UCLA

Dr. Kasahara received his medical degree from Tokyo Medical & Dental University in Japan, and completed clinical training and Board certification in Laboratory Medicine / Clinical Pathology at the University of California, San Francisco (UCSF), where he also received his Ph.D. from the Interdepartmental Program in Endocrinology / Physiology. He was previously on the faculty in the Department of Pathology and Institute for Genetic Medicine at the University of Southern California, before being recruited to the UCLA Division of Digestive Diseases in 2003. In addition to being Professor of Medicine and Molecular & Medical Pharmacology at UCLA, Dr. Kasahara serves as Director of the Vector Core Facility for the CURE Digestive Disease Research Center and the Vector Shared Resource for the UCLA Jonsson Comprehensive Cancer Center, and as Associate Medical Director of the HLA Immunogenetics Lab at the Mendez National Institute of Transplantation in Los Angeles. He has served two terms as a member of the Scientific Committee on Viral Gene Transfer Vectors for the American Society of Gene & Cell Therapy (ASGCT), he is a member of the Board of Councilors for the Japan Society of Gene Therapy (JSGT), and is currently President of the International Society for Cell & Gene Therapy of Cancer (ISGCT).

Dr. Kasahara's research program is primarily focused on gene therapy for cancer, transplantation, and regenerative medicine. His lab is currently working on novel therapeutic applications of conventional retrovirus-, lentivirus-, and adenovirus-based vectors, as well as the development of novel gene delivery vector systems, including hybrid adenovirus-retrovirus vectors and replication-competent viruses targeted to cancer cells. Currently funded projects span three different areas: 1) translational development of tumor-selective replicating retroviral vectors (RRV) for gene therapy of cancer, which has recently started clinical trials; 2) genetic engineering of mesenchymal stem cells and cytotoxic T lymphocytes to serve as tumor-homing vector producer cells, and the development of combined strategies for cancer gene therapy and immunotherapy; and 3) genetic modulation of cellular histocompatibility to improve immunological tolerance, and genetic engineering of drug resistance to enable in vivo chemoselection of transplanted cells, for improvement of allogeneic stem cell transplantation.

http://gastro.ucla.edu/body.cfm?id=156

Neuromics website (Quincy Tam image)......

http://www.neuromics.com/ittrium/visit/A1x66x1y1x85b0x1x9dy1xe3x1y1xd0dx1y1x8b38x1